A deep-learning classifier identifies patients with clinical heart failure using whole-slide images of H&E tissue

Jeffrey J Nirschl1, Andrew Janowczyk2, Eliot G Peyster3

  • 1Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.

Plos One
|April 4, 2018
PubMed

Insights

Deep learning models can now detect heart failure from heart tissue images with high accuracy. This artificial intelligence approach surpasses human expert performance, offering a more reliable diagnostic tool for cardiac conditions.

Area of Science:

  • Cardiology
  • Pathology
  • Artificial Intelligence

Background:

  • Heart failure affects over 26 million people globally each year.
  • Endomyocardial biopsy (EMB) is the gold-standard for diagnosing heart failure when the cause is unknown.
  • Manual interpretation of EMB slides suffers from significant inter-rater variability.

Purpose of the Study:

  • To develop and evaluate a deep convolutional neural network (CNN) classifier for detecting clinical heart failure from H&E stained whole-slide images.
  • To assess the CNN's performance against conventional methods and expert pathologists.

Main Methods:

  • A CNN classifier was trained on H&E stained whole-slide images from 104 patients with heart failure.
  • The CNN model was independently tested on images from 105 patients.
  • Performance was evaluated using sensitivity, specificity, and comparison to expert pathologist diagnoses.

Main Results:

  • The CNN achieved 99% sensitivity and 94% specificity in identifying heart failure or severe pathology on the independent test set.
  • The CNN classifier outperformed conventional feature-engineering approaches.
  • The deep learning model demonstrated superior performance compared to two expert pathologists, exceeding their accuracy by nearly 20%.

Conclusions:

  • Deep learning analysis of endomyocardial biopsy images offers a highly accurate and reproducible method for detecting heart failure.
  • This AI-driven approach has the potential to improve diagnostic consistency and predict cardiac outcomes.
  • The study highlights the transformative potential of artificial intelligence in cardiovascular pathology and diagnostics.

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
637
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K